What one share of Adlai Nortye holds
We are a global clinical-stage company at the forefront of discovering and developing innovative cancer therapies. Leveraging our dual R&D presence in the U.S. and China, we are building a robust pipeline of drug candidates focused on two key areas where we believe we can make a significant difference.
Adlai Nortye’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $0.16 |
|---|---|
| Profit | −$1.11 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$1.05 |
| Cash and investments | $0.25 |
| Debt | $0.82 |
| Book value | −$0.26 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $5.39 | −$6.68 | $0.12 | −$0.48 | — | −$21.87 |
| 2022 | — | −$6.93 | $0.15 | −$5.24 | — | −$17.90 |
| 2023 | $0.35 | −$7.56 | $0.01 | −$3.94 | — | $5.19 |
| 2024 | — | −$1.62 | $0.01 | −$1.63 | — | $0.80 |
| 2025 | $0.16 | −$1.11 | $0.01 | −$1.05 | — | −$0.26 |
Common questions about Adlai Nortye
How much does one share of Adlai Nortye earn?
Over its latest fiscal year, Adlai Nortye lost $1.11 for each share on $0.16 of sales.
Does Adlai Nortye pay a dividend?
Adlai Nortye didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Adlai Nortye’s book value per share?
Adlai Nortye’s book value is negative (−$0.26 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of December 31, 2025.
How much cash and debt does each share of Adlai Nortye have?
Each share of Adlai Nortye has $0.25 of cash and investments and $0.82 of debt, as of December 31, 2025.
What is Adlai Nortye’s free cash flow per share?
−$1.05 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Adlai Nortye bought back shares?
Adlai Nortye’s share count rose about 277% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.